# CD133+ Cell Therapy for Refractory Coronary Heart Disease

> **NCT01049867** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Hospital y Clinica OCA, S.A. de C.V.** · enrollment: 10 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **PROCEDURE:** Intracoronary Infusion of CD133+ Cells

## Key facts

- **NCT ID:** NCT01049867
- **Lead sponsor:** Hospital y Clinica OCA, S.A. de C.V.
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-12
- **Primary completion:** 2010-12
- **Final completion:** 2011-06
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2010-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01049867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01049867, "CD133+ Cell Therapy for Refractory Coronary Heart Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01049867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*